In medical terms, RA stands for rheumatoid arthritis, an autoimmune disease in which the immune system attacks the body’s own joint tissues. Unlike osteoarthritis, which results from wear and tear on cartilage, RA is driven by immune system malfunction and can affect the entire body. Around 18 million people worldwide live with the condition, and women account for roughly 70% of cases.
How RA Affects the Joints
A healthy joint is lined with a thin membrane called the synovium, normally just one to three cells thick. In RA, the immune system sends waves of inflammatory cells into this lining, causing it to swell to eight to ten cells thick. New blood vessels grow into the inflamed tissue, feeding it and allowing it to expand further. This overgrown tissue, called pannus, gradually invades and erodes the cartilage and bone underneath.
The damage isn’t slow. Bone erosion and cartilage destruction can appear within the first two years of disease onset and continue progressing over time if the inflammation isn’t controlled. That timeline is why early diagnosis and treatment matter so much: once bone is eroded, it doesn’t grow back.
Symptoms and What They Feel Like
The hallmark of RA is joint pain, swelling, and stiffness that tends to be symmetrical. If your left wrist is affected, your right wrist likely will be too. Morning stiffness is a key distinguishing feature. It typically lasts 45 minutes or longer and improves with movement throughout the day. By contrast, stiffness from osteoarthritis usually fades within a few minutes.
RA most often starts in the small joints of the hands and feet, then can spread to the wrists, elbows, knees, and ankles. Beyond the joints, the underlying inflammation can affect other parts of the body, including the heart, lungs, and eyes, because the immune dysfunction is systemic rather than limited to one spot.
Who Is Most at Risk
Women are two to three times more likely to develop RA than men, and the disease most commonly appears between ages 30 and 60, though it can start at any age. Genetics play a significant role: specific immune-related genes increase susceptibility, and having a close family member with RA raises your own risk. Environmental factors interact with that genetic foundation. Smoking is one of the strongest known environmental triggers, particularly in people who already carry the relevant genetic variants.
How RA Is Diagnosed
There is no single test that confirms RA. Doctors use a combination of physical examination, blood work, and imaging to reach a diagnosis. The process typically starts when a provider identifies joint swelling (synovitis) that isn’t better explained by another condition.
Two blood tests are central to the workup. The first checks for rheumatoid factor (RF), an antibody found in many people with RA. The second looks for anti-CCP antibodies, which are more specific to the disease. Anti-CCP antibodies are found in most people with RA and are almost never present in people without it. The combination of both tests provides the clearest picture:
- Positive CCP and positive RF: strongly suggests RA.
- Positive CCP and negative RF: may indicate early-stage RA or future development of the disease.
- Both negative: RA is less likely, though not completely ruled out.
Additional blood tests measure general inflammation levels, including C-reactive protein and erythrocyte sedimentation rate (ESR). Joint X-rays help identify any erosion that has already occurred, and fluid drawn from a swollen joint can be analyzed to rule out other causes like gout or infection.
Rheumatologists use a formal scoring system that adds up points across four categories: how many joints are involved, whether blood markers are positive, whether inflammation levels are elevated, and how long symptoms have lasted. A score of 6 or higher out of 10 points to a definite RA diagnosis.
How RA Is Treated
The goal of RA treatment is to slow or stop the immune attack before it causes permanent joint damage. The main medications used are called disease-modifying antirheumatic drugs, or DMARDs. These come in two broad categories.
Traditional DMARDs work by broadly dialing down the overactive immune response. Methotrexate is the most commonly prescribed and is often the first medication tried. If a traditional DMARD alone doesn’t bring symptoms under control, doctors may add or switch to a biologic DMARD. Biologics are more targeted. They block specific components of the immune system that drive inflammation, such as proteins that amplify the inflammatory cycle, or particular types of immune cells that attack the joints.
Treatment usually begins as soon as possible after diagnosis because early, aggressive control of inflammation gives the best long-term outcomes. Most people with RA take their medications long-term, and periodic blood tests and imaging help track whether the disease is well controlled or whether a change in approach is needed.
Living With RA Long Term
RA is a chronic condition, but the outlook has improved dramatically over the past two decades thanks to more targeted therapies and the shift toward treating early. Many people achieve what’s called remission or low disease activity, meaning minimal symptoms and little to no ongoing joint damage. Regular physical activity, particularly low-impact exercise like swimming and walking, helps maintain joint flexibility and muscle strength. Periods of increased symptoms, known as flares, can still occur even with good treatment and may require temporary adjustments to medication.
Because RA is a systemic disease, people with the condition have a higher baseline risk for cardiovascular problems and lung complications over time. Staying on top of inflammation control through medication and regular follow-up with a rheumatologist reduces those risks significantly.